RACCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Research Alliance Corp III
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$10.23+0.07 (+0.69%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
5 of Research Alliance Corp III's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 26, 2026 | Jul 27, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | Jul 2, 2026 | SEC EDGAR |
| Current report | 8-K | May 21, 2026 | May 28, 2026 | SEC EDGAR |
| Current report | 8-K | May 19, 2026 | May 21, 2026 | SEC EDGAR |